CD47 is a Potential Target for the Treatment of Laryngeal Squamous Cell Carcinoma

Article English OPEN
ChunPing Yang; ShuFeng Gao; HaiZhen Zhang; Lian Xu; JianGuo Liu; Meiqun Wang; ShaoRong Zhang;
  • Publisher: Cell Physiol Biochem Press GmbH & Co KG
  • Journal: Cellular Physiology and Biochemistry (issn: 1015-8987, eissn: 1421-9778)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.1159/000452530
  • Subject: Therapy | Laryngeal squamous cell carcinoma | CD47 | siRNA | Monoclonal antibody | Physiology | QP1-981 | Biochemistry | QD415-436

Background/Aims: This study aims to investigate the effect of CD47 on the development of laryngeal squamous cell carcinoma (LSCC) and the therapeutic potential of monoclonal antibody against CD47 and its ligand SIRPα in the treatment of LSCC. Methods: We firstly detecte... View more
Share - Bookmark